Policy Makers

This report summarizes the critical role urbanization practices play in large cities and how they can be used to end the AIDS epidemic by 2030.

AIDSVu offers a variety of ready-made materials and data sets to help illustrate the impact of HIV in the United States. This report presents the state of HIV/AIDS in the United States using 2012 data.

This report evaluates the current needs, protocols, and promising practices for latent tuberculosis infection (LTBI) and tuberculosis (TB) screening, testing, and treatment among community health centers serving Asian American/Asian (A/AA) and Native Hawaiian/Pacific Islander (NH/PI) populations.

This report summarizes the TB Elimination Alliance's (TEA) activities and outcomes from 2019 to 2024.

This webpage explains Assembly Bill 2132, which mandates tuberculosis (TB) risk assessment and testing for adult primary care patients in California.

This fact sheet addresses common questions about insurance coverage for viral hepatitis prevention and treatment services. It outlines coverage details for hepatitis A and B vaccinations, hepatitis B and C screenings, and treatments across various insurance types, including Medicaid, Medicare, and private plans.

This report provides an early analysis of cases of tuberculosis (TB) disease reported to the Centers for Disease Control and Prevention (CDC) during 2024 as compared with previous years. CDC used U.S. Census Bureau population estimates to calculate rates (cases per 100,000 persons) of TB disease.

This report outlines the National Institute of Allergy and Infectious Diseases' (NIAID) updated strategic plan to combat tuberculosis. It focuses on four key priorities: enhancing fundamental knowledge of TB, advancing diagnostic research, accelerating vaccine development, and supporting strategies to treat and prevent TB.

This journal discusses the integration of hepatitis C management into primary care as a key strategy for eliminating the disease. It examines barriers to care, the role of direct-acting antivirals, and the importance of screening and treatment within primary care settings.

This journal examines the clinical course of autoimmune hepatitis (AIH) in Hispanic and African American patients at a South Bronx hospital. The findings contribute to a better understanding of AIH in diverse racial and ethnic groups, emphasizing the need for tailored healthcare strategies.